Ir.tevapharm.com

Teva Pharmaceutical Industries Ltd.

WEB“Community Routes: Access to Mental Health Care” helps uninsured patients access healthcare for anxiety and depression, and is a partnership between Direct …

Actived: 5 days ago

URL: https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2023/U.S.-Mental-Health-Access-Program-Expands-Medicine-Donation-to-Seven-New-States/default.aspx

Teva to Provide Second Round of Funding to Clinics in California

WEBGrant funding of $75,000 to each clinic is part of Teva’s $2 million, two-year commitment to support clinics’ innovative mental and behavioral health programs tailored to meet …

Category:  Health Go Health

Teva Reports Growth in Fourth Quarter and Full Year 2023

WEB2023 revenues of $15.8 billion reflect an increase of 7% in local currency terms, compared to 2022 AUSTEDO ® - exceeding $1.2 billion in annual revenues, up …

Category:  Health Go Health

Teva’s 2023 Healthy Future Report Showcases Renewed …

WEBTeva’s 2023 Healthy Future Report highlights the Company’s renewed sustainability strategy, which guides Teva in addressing global challenges while also …

Category:  Health Go Health

Teva Launches New “Pivot to Growth” Strategy

WEBReturn to growth by accelerating a strong innovative medicines portfolio Expand innovative pipeline and focus on core therapeutic areas with first-in-class and …

Category:  Medicine Go Health

Press Release Details

WEBNew once-daily AUSTEDO XR regimen now approved in 6, 12, and 24 mg tablet strengths AUSTEDO is the only vesicular monoamine transporter 2 (VMAT2) …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBSix abstracts to be presented highlighting results of AJOVY preventive treatment in patients with migraine Oral presentation will feature data from the UNITE …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBCollaboration will integrate data into hospital patient workflows, supporting remote chronic care and population health management Teva Pharmaceuticals, a U.S. …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBCalifornia’s Desert Oasis Healthcare (DOHC) implements Rimidi’s Respiratory Module for respiratory patient monitoring, based on data collected by Teva’s …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBCollaboration will integrate data into healthcare provider workflows, supporting remote chronic care and population health management Teva …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBSIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBNet income attributable to Teva and diluted earnings per share in the third quarter of 2023 were $80 million and $0.07, respectively, compared to $56 million and …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBReal-world insights fueled by Digihaler technology and utility of its data in patients with asthma Digihaler is the first and only smart inhaler system that can provide …

Category:  Health Go Health

Teva Presents New Data Supporting Safety, Tolerability and Target

WEBResults demonstrate rapid and sustained suppression of free TL1A, confirming target engagement of anti-TL1A (TEV-’574)1 Anti-TL1A (TEV-’574) was …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBAlmost half of all migraine patients experience depression and anxiety1 Migraine patients treated with AJOVY ® (fremanezumab) showed significant reductions …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBSTART study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia (TD), including utilization and patient …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBLaunched five access to medicines programs as of 2022 (63% of 2025 target); donated $699.6 million worth of medicines to patients in need Reduced absolute …

Category:  Medicine Go Health

Teva Pharmaceutical Industries Ltd.

WEBAlvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBAJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set …

Category:  Health Go Health

Teva Pharmaceutical Industries Ltd.

WEBThe intended divestiture is expected to play an important role in Teva's “Pivot to Growth” strategy as it will allow Teva to focus on its core business strengths and on …

Category:  Health Go Health